These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 2905765

  • 1. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.
    Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765
    [Abstract] [Full Text] [Related]

  • 2. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 3. Biochemical and behavioural effects of isamoltane, a beta-adrenoceptor antagonist with affinity for the 5-HT1B receptor of rat brain.
    Rényi L, Larsson LG, Berg S, Svensson BE, Thorell G, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan 26; 343(1):1-6. PubMed ID: 1674359
    [Abstract] [Full Text] [Related]

  • 4. Interactions of carteolol and other beta-adrenoceptor blocking agents with serotonin receptor subtypes.
    Nishio H, Nagakura Y, Segawa T.
    Arch Int Pharmacodyn Ther; 1989 Jan 26; 302():96-106. PubMed ID: 2576893
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):1-12. PubMed ID: 3002805
    [Abstract] [Full Text] [Related]

  • 6. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 26; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 7. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E, Goldstein M, Bohmaker K.
    Mol Pharmacol; 1990 Feb 26; 37(2):231-7. PubMed ID: 1968223
    [Abstract] [Full Text] [Related]

  • 8. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V, Ahlenius S.
    Br J Pharmacol; 1998 Dec 26; 125(8):1733-43. PubMed ID: 9886765
    [Abstract] [Full Text] [Related]

  • 9. Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?
    Kaur P, Ahlenius S.
    J Neural Transm (Vienna); 2000 Dec 26; 107(8-9):903-17. PubMed ID: 11041271
    [Abstract] [Full Text] [Related]

  • 10. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 11. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 06; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 12. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ, Palmier C.
    Neuropharmacology; 1994 Jan 06; 33(1):67-75. PubMed ID: 7910388
    [Abstract] [Full Text] [Related]

  • 13. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug 06; 327(1):18-22. PubMed ID: 6238235
    [Abstract] [Full Text] [Related]

  • 14. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
    Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 06; 332(1):1-7. PubMed ID: 2936965
    [Abstract] [Full Text] [Related]

  • 15. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.
    Assie MB, Koek W.
    Neuropharmacology; 1996 Feb 06; 35(2):213-22. PubMed ID: 8734491
    [Abstract] [Full Text] [Related]

  • 16. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
    Chaouloff F, Aguerre S, Mormede P.
    Neuropharmacology; 1998 Sep 06; 37(9):1159-67. PubMed ID: 9833646
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.